Global Bacterial Conjunctivitis Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 to 2025

  • ID: 4431914
  • Report
  • Region: Global
  • Acute Market Reports
1 of 4

FEATURED COMPANIES

  • Actavis Plc.
  • Akorn, Inc.
  • Bayer AG
  • F.Hoffman La-Roche Ltd.
  • Merck & Co., Inc.
  • Novartis AG
  • MORE
Bacterial Conjunctivitis Market - Growth, Future Prospects, Competitive Analysis, 2017 - 2025, the global bacterial conjunctivitis market was valued at US$ 458.4 Mn in 2016, and is expected to reach US$ 436.7 Mn by 2025 decreasing at a CAGR of - 0.54% from 2017 to 2025.

Market Insights

Conjunctiva is a delicate lining that covers the eyelids and is part of the outer surface of the eyeball. Bacterial conjunctivitis results when the conjunctiva is inflamed by bacteria, allergies or chemical irritants. The market is highly dynamic as currently very few investigative studies are being conducted with a weak product pipeline, owing to drug expiry issues, generic version of the antibiotics are going to dominate the market throughout the forecast period 2017-2025.

In 2016, fluoroquinolones segment held the largest market share chiefly due to factors such as the broad spectrum antimicrobial activity offered by fluoroquinolones against the Gram-positive, Gram-negative and anaerobic organism. The limitations of this segment throughout the forecast period are the forthcoming patent expiration of blockbuster branded drugs of the fluoroquinolones drug class. Aminoglycosides and macrolides together will be the fastest growing segment throughout the forecast period 2017-2025. Factors contributing to the growth of this segment are increasing incidences of antibiotics related drug resistance in bacterial conjunctivitis patients and technological advancement with effective clinical trials conducted analyzing the safety and efficacy of the antibiotic drug formulations at different concentrations resulting in immediate relief due to immediate onset of action.

In 2016, North America held the largest revenue share mainly due to factors such as rising prevalence of bacterial conjunctivitis, affordable reimbursement scenario and presence of developed research and healthcare institutions. Asia Pacific will be the fastest growing market throughout the forecast period 2017-2025, majorly due to factors such as high competition due to presence of existing and budding biopharmaceutical manufacturers involved in producing products for bacterial conjunctivitis treatment in this regions and supportive regulatory environment for bacterial conjunctivitis products and increasing disposable incomes.

Key Market Movements:
  • Rising prevalence of bacterial conjunctivitis
  • Rising public awareness regarding eye infections resulting in immediate treatment
  • Increasing air and water pollution and lack of self-hygiene
  • Supportive regulatory environment for bacterial conjunctivitis products
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Actavis Plc.
  • Akorn, Inc.
  • Bayer AG
  • F.Hoffman La-Roche Ltd.
  • Merck & Co., Inc.
  • Novartis AG
  • MORE
Chapter 1. Preface
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase III-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted

Chapter 2. Executive Summary
2.1. Global Bacterial Conjunctivitis Market Portraiture
2.1.1. Global Bacterial Conjunctivitis Market, by Drug Class, 2016
2.1.2. Global Bacterial Conjunctivitis Market, by Geography, 2016

Chapter 3. Bacterial Conjunctivitis: Market Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography
3.6. Competitive Landscape
3.6.1. Competitive Landscape, by Key Players, 2016

Chapter 4. Global Bacterial Conjunctivitis Market, by Drug Class, 2015 - 2025 (US$ Mn)
4.1. Overview
4.2. Attractive Investment Proposition: Global Bacterial Conjunctivitis Market, by Drug Class
4.3. Fluoroquinolones
4.3.1. Ciprofloxacin
4.3.2. Ofloxacin
4.3.3. Levofloxacin
4.3.4. Moxifloxacin
4.3.5. Gatifloxacin
4.3.6. Besifloxacin
4.4. Aminoglycosides
4.4.1. Tobramycin
4.4.2. Gentamycin
4.5. Macrolides
4.5.1. Erythromycin
4.5.2. Azithromycin
4.6. Others (Phenicols, Glycolipopeptides, Cyclic Polypeptides)

Chapter 5. Global Bacterial Conjunctivitis Market, by Product Pipeline
5.1. Overview
5.2. Phase III Drug - Till 2025 (US$ Mn)
5.2.1. Vancomycin 1.1% Ointment
5.3. Phase II Drug (Qualitative Information)
5.3.1. PRO -

Chapter 6. Global Bacterial Conjunctivitis Market, by Geography, 2015 - 2025 (US$ Mn)
6.1. Overview
6.2. North America Bacterial Conjunctivitis Market Analysis, 2015 - 2025
6.2.1. North America Bacterial Conjunctivitis Market, by Drug Class, 2015 - 2025 (US$ Mn)
6.2.2. North America Bacterial Conjunctivitis Market, by Country, 2015 - 2025 (US$ Mn)
6.2.2.1. U.S.
6.2.2.2. Canada
6.3. Europe Bacterial Conjunctivitis Market Analysis, 2015 - 2025
6.3.1. Europe Bacterial Conjunctivitis Market, by Drug Class, 2015 - 2025 (US$ Mn)
6.3.2. Europe Bacterial Conjunctivitis Market, by Country, 2015 - 2025 (US$ Mn)
6.3.2.1. U.K.
6.3.2.2. Germany
6.3.2.3. Rest of Europe
6.4. Asia Pacific Bacterial Conjunctivitis Market Analysis, 2015 - 2025
6.4.1. Asia Pacific Bacterial Conjunctivitis Market, by Drug Class, 2015 - 2025 (US$ Mn)
6.4.2. Asia Pacific Bacterial Conjunctivitis Market, by Country, 2015 - 2025 (US$ Mn)
6.4.2.1. Japan
6.4.2.2. China
6.4.2.3. India
6.4.2.4. Rest of APAC
6.5. Latin America Bacterial Conjunctivitis Market Analysis, 2015 - 2025
6.5.1. Latin America Bacterial Conjunctivitis Market, by Drug Class, 2015 - 2025 (US$ Mn)
6.5.2. Latin America Bacterial Conjunctivitis Market, by Country, 2015 - 2025 (US$ Mn)
6.5.2.1. Brazil
6.5.2.2. Mexico
6.5.2.3. Rest of Latin America
6.6. Middle East & Africa (MEA) Bacterial Conjunctivitis Market Analysis, 2015 - 2025
6.6.1. MEA Bacterial Conjunctivitis Market, by Drug Class, 2015 - 2025 (US$ Mn)
6.6.2. MEA Bacterial Conjunctivitis Market, by Region, 2015 - 2025 (US$ Mn)
6.6.2.1. GCC
6.6.2.2. Rest of MEA

Chapter 7. Company Profiles
7.1. Actavis Plc.
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Product Portfolio
7.1.4. Key Developments
7.2. Akorn, Inc.
7.3. Bayer AG
7.4. F.Hoffman La-Roche Ltd.
7.5. InSite Vision Incorporated
7.6. Merck & Co., Inc.
7.7. Novartis AG
7.8. Perrigo Company Plc.
7.9. Pfizer, Inc.
7.10. Santen Pharmaceutical Co., Ltd.
7.11. Other Notable Players

List of Figures
Fig. 1 Bacterial Conjunctivitis: Market Segmentation
Fig. 2 Global Bacterial Conjunctivitis Market Share, by Drug Class, 2016 (Value %)
Fig. 3 Global Bacterial Conjunctivitis Market Share, by Geography, 2016 (Value %)
Fig. 4 Attractive Investment Proposition, by Geography
Fig. 5 Market Competition Landscape, by Key Players, 2016
Fig. 6 Global Ciprofloxacin Market, 2015 - 2025 (US$ Mn)
Fig. 7 Global Ofloxacin Market, 2015 - 2025 (US$ Mn)
Fig. 8 Global Levofloxacin Market, 2015 - 2025 (US$ Mn)
Fig. 9 Global Moxifloxacin Market, 2015 - 2025 (US$ Mn)
Fig. 10 Global Gatifloxacin Market, 2015 - 2025 (US$ Mn)
Fig. 11 Global Besifloxacin Market, 2015 - 2025 (US$ Mn)
Fig. 12 Global Tobramycin Market, 2015 - 2025 (US$ Mn)
Fig. 13 Global Gentamycin Market, 2015 - 2025 (US$ Mn)
Fig. 14 Global Erythromycin Market, 2015 - 2025 (US$ Mn)
Fig. 15 Global Azithromycin Market, 2015 - 2025 (US$ Mn)
Fig. 16 Global Other Drug Class for Bacterial Conjunctivitis Market, 2015 - 2025 (US$ Mn)
Fig. 17 Global Phase III Drug Market for Bacterial Conjunctivitis, Till - 2025 (US$ Mn)
Fig. 18 U.S. Bacterial Conjunctivitis Market, 2015 - 2025 (US$ Mn)
Fig. 19 Canada Bacterial Conjunctivitis Market, 2015 - 2025 (US$ Mn)
Fig. 20 U.K. Bacterial Conjunctivitis Market, 2015 - 2025 (US$ Mn)
Fig. 21 Germany Bacterial Conjunctivitis Market, 2015 - 2025 (US$ Mn)
Fig. 22 Rest of Europe Bacterial Conjunctivitis Market, 2015 - 2025 (US$ Mn)
Fig. 23 Japan Bacterial Conjunctivitis Market, 2015 - 2025 (US$ Mn)
Fig. 24 China Bacterial Conjunctivitis Market, 2015 - 2025 (US$ Mn)
Fig. 25 India Bacterial Conjunctivitis Market, 2015 - 2025 (US$ Mn)
Fig. 26 Rest of Asia Pacific Bacterial Conjunctivitis Market, 2015 - 2025 (US$ Mn)
Fig. 27 Brazil Bacterial Conjunctivitis Market, 2015 - 2025 (US$ Mn)
Fig. 28 Mexico Bacterial Conjunctivitis Market, 2015 - 2025 (US$ Mn)
Fig. 29 Rest of Latin America Bacterial Conjunctivitis Market, 2015 - 2025 (US$ Mn)
Fig. 30 GCC Bacterial Conjunctivitis Market, 2015 - 2025 (US$ Mn)
Fig. 31 Rest of Middle East and Africa Bacterial Conjunctivitis Market, 2015 - 2025 (US$ Mn)

List of Tables
Table 1 Global Bacterial Conjunctivitis Market, by Drug Class, 2015 - 2025 (US$ Mn)
Table 2 Global Fluoroquinolones Market for Bacterial Conjunctivitis, 2015 - 2025 (US$ Mn)
Table 3 Global Aminoglycosides Market for Bacterial Conjunctivitis, 2015 - 2025 (US$ Mn)
Table 4 Global Macrolides Market for Bacterial Conjunctivitis, 2015 - 2025 (US$ Mn)
Table 5 Global Bacterial Conjunctivitis Market, by Geography, 2015 - 2025 (US$ Mn)
Table 6 North America Bacterial Conjunctivitis Market, by Drug Class, 2015 - 2025 (US$ Mn)
Table 7 North America Bacterial Conjunctivitis Market, by Country, 2015 - 2025 (US$ Mn)
Table 8 Europe Bacterial Conjunctivitis Market, by Drug Class, 2015 - 2025 (US$ Mn)
Table 9 Europe Bacterial Conjunctivitis Market, by Country, 2015 - 2025 (US$ Mn)
Table 10 Asia Pacific Bacterial Conjunctivitis Market, by Drug Class, 2015 - 2025 (US$ Mn)
Table 11 Asia Pacific Bacterial Conjunctivitis Market, by Country, 2015 - 2025 (US$ Mn)
Table 12 Latin America Bacterial Conjunctivitis Market, by Drug Class, 2015 - 2025 (US$ Mn)
Table 13 Latin America Bacterial Conjunctivitis Market, by Country, 2015 - 2025 (US$ Mn)
Table 14 Middle East and Africa Bacterial Conjunctivitis Market, by Drug Class, 2015 - 2025 (US$ Mn)
Table 15 Middle East and Africa Bacterial Conjunctivitis Market, by Region, 2015 - 2025 (US$ Mn)
Table 16 Actavis Plc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
Table 17 Akorn, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
Table 18 Bayer AG: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
Table 19 F.Hoffman La-Roche Ltd.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
Table 20 InSite Vision Incorporated.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
Table 21 Merck & Co., Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
Table 22 Novartis AG: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
Table 23 Perrigo Company Plc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
Table 24 Pfizer, Inc..: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
Table 25 Santen Pharmaceutical Co., Ltd.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Actavis Plc.
  • Akorn, Inc.
  • Bayer AG
  • F.Hoffman La-Roche Ltd.
  • InSite Vision Incorporated
  • Merck & Co., Inc.
  • Novartis AG
  • Perrigo Company Plc.
  • Pfizer, Inc.
  • Santen Pharmaceutical Co., Ltd.
  • Other Notable Players
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll